US-based ARS’s nasal spray to treat allergic reactions gets FDA nod
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.
Drugs
Health
Pharma
Drugs
Health
Pharma
US regulator rejects Lykos’s MDMA therapy, wants more data
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.
Drugs
Health
Pharma
‘Sharenting’: The risks of oversharing your children’s life online
When parents share unflattering or embarrassing images, it can lead to feelings of humiliation and a distorted self-image. Children may struggle with their.
Drugs
Health
Pharma
Citius’s blood cancer drug gets US regulatory body’s clearance
Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare.
Drugs
Health
Pharma
Purdue Pharma’s opioid overdose drug gets US regulator’s nod
US drugmaker Purdue Pharma’s injection to treat opioid overdose in adults and patients 12 years or older, got the country’s drug regulator’s approval.
Drugs
Health
Pharma
Covid-19 vaccines saved 1.6 million lives in Europe, most in Omicron wave
Vaccinations have saved more than 1.6 million lives in the WHO European Region and Covid-19 is lurking around the world menacingly with its.
Drugs
Health
Pharma
Merck halts small cell lung cancer immunotherapy drug trial
Merck has stopped an end-stage combination immunotherapy trial for a lung cancer condition, following recommendations of an independent data monitoring committee, which indicated.
Drugs
Health
Pharma
Novartis’s drug to treat rare kidney disease gets USFDA approval
Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of.
Drugs
Health
Pharma
Denmark’s Pharmacosmos to buy G1 Therapeutics for $405 million
Danish biotechnology company, Pharmacosmos A/S will buy US-based G1 Therapeutics Inc., for $405 million to expand its global commercial portfolio in haematology.
Drugs
Health
Pharma
WHO: 40 athletes participating in Olympic Games test Covid-19 positive
The WHO’s event-based surveillance system has reported that at least 40 athletes participating in the Olympic Games in France had tested positive for.